EWA LLC’s Generation Bio GBIO Stock Holding History

EWA LLC’s Portfolio GBIO Stock Details GBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-9,290	Closed	-$37.6K	–	223
2025 Q1	$37.6K	Buy	+9,290	New	+$65.3K	0.01%	175

Other funds holding GBIO

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

AVLSA

Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

EWA LLC's GBIO Position: Q2 2025 in Review

EWA LLC sold out of Generation Bio (GBIO) in Q2 2025, closing a stake of 9,290 shares — an estimated $37.6K sold.

EWA LLC first reported a position in GBIO in Q1 2025 and held it in 1 quarter. The position peaked at $37.6K in Q1 2025. 61 funds tracked by Wall St. Rank hold GBIO as of Q2 2025.

EWA LLC reported no remaining Generation Bio position as of Q2 2025 after selling out during the quarter.
EWA LLC sold 9,290 Generation Bio shares in Q2 2025, an estimated $37.6K.
EWA LLC first reported a position in Generation Bio in Q1 2025 and held it in 1 quarter.
EWA LLC's Generation Bio position peaked at $37.6K in Q1 2025.
61 funds tracked by Wall St. Rank held Generation Bio as of Q2 2025.

Based on EWA LLC's 13F filing for Q2 2025, filed 18 Jul 2025.